Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143412 |
| CAS No | NA |
| Mol.F. | C24H24F2N6O3 |
| Mol.Wt. | 482.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143413 |
| CAS No | NA |
| Mol.F. | C29H32F2N6O5 |
| Mol.Wt. | 582.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143414 |
| CAS No | NA |
| Mol.F. | C23H25BF2N2O4 |
| Mol.Wt. | 442.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143415 |
| CAS No | NA |
| Mol.F. | C26H24F2N6O4 |
| Mol.Wt. | 522.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143416 |
| CAS No | NA |
| Mol.F. | C21H22N2O5S |
| Mol.Wt. | 414.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143417 |
| CAS No | NA |
| Mol.F. | C12H14N2O4S |
| Mol.Wt. | 282.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143418 |
| CAS No | NA |
| Mol.F. | C14H16N2O5S |
| Mol.Wt. | 324.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143419 |
| CAS No | NA |
| Mol.F. | C24H27N3O7S2 |
| Mol.Wt. | 533.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143420 |
| CAS No | NA |
| Mol.F. | C19H20N2O4S |
| Mol.Wt. | 372.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143421 |
| CAS No | NA |
| Mol.F. | C38H39N3O7S2 |
| Mol.Wt. | 713.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143422 |
| CAS No | NA |
| Mol.F. | C19H18N2O4 |
| Mol.Wt. | 338.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143423 |
| CAS No | NA |
| Mol.F. | C13H16N2O4S |
| Mol.Wt. | 296.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143424 |
| CAS No | NA |
| Mol.F. | C15H18N2O5S |
| Mol.Wt. | 338.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143425 |
| CAS No | NA |
| Mol.F. | C21H22N2O6S |
| Mol.Wt. | 430.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143426 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143427 |
| CAS No | NA |
| Mol.F. | C18H22N2O3 |
| Mol.Wt. | 314.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |